Disease- and cell-type-specific transcriptional targeting of vectors for osteoarthritis gene therapy: Further development of a clinical canine model

Rheumatology

Volumn 44, Issue 6, 2005, Pages 735-743

  Campbell, S E ^b   Bennett, D ^b   Nasir, L ^b   Gault, E A ^b   Argyle, D J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Canine model; Gene therapy; Osteoarthritis; Transcription

Indexed keywords

COLLAGEN TYPE 11; CYTOKINE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LUCIFERASE; TRANSCRIPTION FACTOR SOX9; TUMOR NECROSIS FACTOR ALPHA; HIGH MOBILITY GROUP PROTEIN; INTERLEUKIN 1; SOX-9 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR;

ARTICLE; CARTILAGE CELL; CELL LINE; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOG; DRUG SAFETY; ENHANCER REGION; GENE DELETION; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE VECTOR; GENETIC ENGINEERING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSGENE; ANIMAL; DISEASE MODEL; GENETICS; INTRON; METHODOLOGY; MUTATION; TUMOR CELL LINE;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; COLLAGEN TYPE XI; DISEASE MODELS, ANIMAL; DOGS; GENE DELETION; GENE THERAPY; GENETIC VECTORS; HIGH MOBILITY GROUP PROTEINS; INTERLEUKIN-1; INTRONS; MATRIX METALLOPROTEINASE 9; MICE; MUTATION; NF-KAPPA B; OSTEOARTHRITIS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 24944439998     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keh590     Document Type: Article

References (36)

1. Miller N, Vile R. Targeted vectors for gene therapy. FASEB J 1995;9:190-9.
2. Cox GA, Cole NM, Matsumura K et al. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 1993;364:725-9.
3. Maxwell IH, Glode LM, Maxwell F. Expression of the diphtheria toxin A-chain coding sequence under the control of promoters and enhancers from immunoglobulin genes as a means of directing toxicity to B-lymphoid cells. Cancer Res 1991;51:4299-304.
4. Hatzoglou M, Lamers W, Bosch F, Wynshaw-Boris A, Clapp DW, Hanson RW. Hepatic gene transfer in animals using retroviruses containing the promoter from the gene for phosphoenolpyruvate carboxykinase. J Biol Chem 1990;265:17285-93.
5. Vile R, Miller N, Chernajovsky Y, Hart I. A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genes. Gene Ther 1994;1:307-16.
6. Mendler M, Eich-Bender SG, Vaughan L, Winterhalter KH, Bruckner P. Cartilage contains mixed fibrils of collagen types II, IX, and XI. J Cell Biol 1989;108:191-7.
7. Campbell SE, Nasir L, Argyle DJ, Bennett D. Molecular cloning and characterisation of canine matrix metalloproteinase-9 (MMP-9) gene promoter. Gene 2001;273:81-7.
8. Siders WM, Halloran PJ, Fenton RG. Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells. Cancer Res 1996;56:5638-46.
9. Ferreira V, Assouline Z, Schwachtgen JL, Bahnak BR, Meyer D, Kerbiriou-Nabias D. The role of the 5′-flanking region in the cell-specific transcription of the human von Willebrand factor gene. Biochem J 1993;293:641-8.
10. Nettelbeck DM, Jerome V, Muller R. A strategy for enhancing the transcriptional activity of weak cell type-specific promoters. Gene Therapy 1998;5:1656-64.
11. Dachs GU, Patterson AV, Firth JD et al. Targeting gene expression to hypoxic tumor cells. Nat Med 1997;3:515-20.
12. Hallahan DE, Mauceri HJ, Seung LP et al. Spatial and temporal control of gene therapy using ionizing radiation. Nat Med 199;1:786-9.
13. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 1995;268:1766-9.
14. Ghersa P, Gobert RP, Sattonnet-Roche P, Richards CA, Merlo Pich E, Hooft van Huijsduijnen R. Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor. Gene Ther 1998;5:1213-20.
15. Vincenti MP, Brinckerhoff CE. Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1beta. Arthritis Res 2001;3:381-8.
16. Cowell S, Knauper V, Stewart ML et al. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: Associated activation of gelatinase A, gelatinase B and collagenase 3. Biochem J 1998;331:453-8.
17. Hattori T, Kubota S, Yutani Y et al. Change in cellular localization of a rheumatoid arthritis-related antigen (RA-A47) with downregulation upon stimulation by inflammatory cytokines in chondrocytes. J Cell Physiol 2001;186:268-81.
18. Wright KM, Friedland JS. Regulation of monocyte chemokine and MMP-9 secretion by proinflammatory cytokines in tuberculous osteomyelitis. J Leukocyte Biol 2004;75:1086-92.
19. Adcock IM. Transcription factors as activators of gene transcription: AP-1 and NF-kappa B. Monaldi Arch Chest Dis 1997;52:178-86.
20. He C. Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. Cancer Lett 1996;106:185-91.
21. Bond M, Fabunmi RP, Baker AH, Newby AC. Synergistic up-regulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor NF-kappa B. FEBS Lett 1998;435:29-34.
22. Schindler U, Baichwal VR. Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol Cell Biol 1994;14:5820-31.
23. Martin T, Cardarelli PM, Parry GC, Felts KA, Cobb RR. Cytokine induction of monocyte chemoattractant protein-1 gene expression in human endothelial cells depends on the cooperative action of NF-kappa B and AP-1. Eur J Immunol 1997;27:1091-7.
24. Allport VC, Slater DM, Newton R, Bennett PR. NF-kappaB and AP-1 are required for cyclo-oxygenase 2 gene expression in amnion epithelial cell line (WISH). Mol Hum Reprod 2000;6:561-5.
25. Taylor BS, de Vera ME, Ganster RW et al. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J Biol Chem 1998;273:15148-56.
26. Liu Y, Li H, Tanaka K, Tsumaki N, Yamada Y. Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2 (XI) collagen gene. J Biol Chem 2000;275:12712-18.
27. Enomoto M, Pan HO, Kinoshita A, Yutani Y, Suzuki F, Takigawa M. Effects of tumor necrosis factor alpha on proliferation and expression of differentiated phenotypes in rabbit costal chondrocytes in culture. Calcif Tissue Int 1990;47:145-51.
28. Ng HH, Bird A. DNA methylation and chromatin modification. Curr Opin Genet Dev 1999;9:158-63.
29. Tsumaki N, Kimura T, Tanaka K, Kimura JH, Ochi T, Yamada Y. Modular arrangement of cartilage- and neural tissue-specific cis-elements in the mouse alpha2(XI) collagen promoter. J Biol Chem 1998;273:22861-4.
30. Roach J, Choi SJ, Schaub RL, Leach RJ, Roodman GD, Reddy SV. Further characterization of the murine collagenase (type IVB) gene promoter and analysis of mRNA expression in murine tissues. Gene 1998;208:117-22.
31. Lefebvre V, Zhou G, Mukhopadhyay K et al. An 18-base-pair sequence in the mouse proalpha1(II) collagen gene is sufficient for expression in cartilage and binds nuclear proteins that are selectively expressed in chondrocytes. Mol Cell Biol 1996;16:4512-23.
32. Morishita M, Kishino T, Furukawa K et al. A 30-base-pair element in the first intron of SOX9 acts as an enhancer in ATDC5. Biochem Biophys Res Commun 2001;288:347-55.
33. Cawston TE. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther 1996;70:163-82.
34. Bennett D, Tennant BT, Baughan J, Carter S, May S, Lewis DG. A reappraisal of anterior cruciate ligament disease in the dog. J Small Animal Pract 1998;29:275-97.
35. Pond MJ, Nuki G. Experimentally-induced osteoarthritis in the dog. Ann Rheum Dis 1973;32:387-8.
36. Wada M, Imura S, Baba H, Shimada S. Knee laxity in patients with osteoarthritis and rheumatoid arthritis. Br J Rheumatol 1996;35:560-3.